Cagrilintide Dosage Calculator & Research Doses

1Set Up Your Mix

2.5 mg/mL · 2500 mcg/mL

1. Pick your peptide

2. How much peptide is in the vial? It's printed on the label — usually something like 5 mg

3. How much water are you adding? More water makes each dose easier to measure

4. How much do you want per dose?

All answers assume a standard 1 mL U-100 syringe, where 1 unit = 0.01 mL. That is the usual insulin syringe and the one every number here is based on.

Your Answer — CagrilintideYour Answer

—

24Draw To This Line

0.24That's This Many mL

8Doses In The Vial

5 mg ÷ 2 mL = 2.5 mg/mL → 0.6 mg ÷ 2.5 mg/mL = 0.24 mL → × 100 = 24 units—

Looks good. Draw to 24 units on a 1 mL syringe. That is an easy amount to measure, and this vial gives you 8 doses.

2Week-By-Week Plan — Cagrilintide

Phase 2 escalation

When	Dose	How Often	How Many mL	Draw To	Number Of Doses
Initiation	0.3 mg	once weekly	0.12 mL	12 u	16 doses
Step	0.6 mg	once weekly	0.24 mL	24 u	8 doses
Step	1.2 mg	once weekly	0.48 mL	48 u	4 doses
Trial max	2.4 mg	once weekly	0.96 mL	96 u	2 doses

Weeks until the top dose

12 weeks

Peptide used getting there

8.4 mg

Vials you'll need

2 × 5 mg

Once you're at the top dose

9.6 mg / 4 wk · 1.92 vials

Where this plan came from

A clinical trial schedule

Where this came from: Lancet phase 2 dose-escalation, four-week steps. Four-week steps. The trial also ran a 4.5 mg arm above the range shown here; exact escalation varied by arm.

3Common Doses — Cagrilintide

worked out for your mix

Level	Dose	How Often	How Many mL	Draw To	Doses In Vial
Weeks 1–4	0.3 mg	once weekly	0.12 mL	12 u	4	1.2 mg
Weeks 5–8	0.6 mg	once weekly	0.24 mL	24 u	4	2.4 mg
Weeks 9–12	1.2 mg	once weekly	0.48 mL	48 u	4	4.8 mg
Week 13 onward per 4 weeks from here on	2.4 mg	once weekly	0.96 mL	96 u	4	9.6 mg

Please read this. These numbers come from published research. They are here as reference, not as instructions. A lot of them come from lab studies rather than studies in people, and some of these peptides have never been given to a person at all.

About CagrilintideAbout This Peptide

Metabolic / Incretin

Also known as

Long-acting amylin analogue

Class

Metabolic / Incretin

Route

Subcutaneous

Half-life

~7–8 days

Evidence tier

Clinical

An amylin analogue studied alone and in fixed combination with semaglutide (CagriSema). Escalation mirrors the GLP-1 pattern.

Buy Cagrilintidethis peptide

Opens optimal-pep.com in a new tab

Where These Numbers Come From

Clinical — Human trial or approved-label dosing published

Once-weekly cagrilintide for weight management — a phase 2 trial Lau DCW, et al. The Lancet, 2021

Dose-ranging source for the 0.3–4.5 mg arms.

Find on PubMed ↗

CagriSema — cagrilintide plus semaglutide combination trials Frías JP, et al. The Lancet, 2023

Combination dosing and additive effect data.

Find on PubMed ↗

Newest Studies — —

—

Not reviewed by us. This list is pulled straight from Europe PMC as papers are published. Nobody has checked whether these are any good, or whether they change anything above. The dose numbers on this page only ever change after a person reviews the evidence.

Research Use Only — Confirm to Continue

Cagrilintide Dosage & Reconstitution

1Set Up Your Mix

Your Answer — CagrilintideYour Answer

2Week-By-Week Plan — Cagrilintide

3Common Doses — Cagrilintide

About CagrilintideAbout This Peptide

Where These Numbers Come From

Newest Studies — —

More peptides

Retatrutide

Survodutide

All 71 peptides